AU2001265248A1 - Measurement of the therapeutic dose for bone marrow ablation therapy - Google Patents

Measurement of the therapeutic dose for bone marrow ablation therapy

Info

Publication number
AU2001265248A1
AU2001265248A1 AU2001265248A AU6524801A AU2001265248A1 AU 2001265248 A1 AU2001265248 A1 AU 2001265248A1 AU 2001265248 A AU2001265248 A AU 2001265248A AU 6524801 A AU6524801 A AU 6524801A AU 2001265248 A1 AU2001265248 A1 AU 2001265248A1
Authority
AU
Australia
Prior art keywords
measurement
bone marrow
therapeutic dose
ablation therapy
marrow ablation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001265248A
Inventor
Jaime Simon
Richard E. Wendt Iii
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
STEVEN MCCULLOUGH
Original Assignee
STEVEN MCCULLOUGH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by STEVEN MCCULLOUGH filed Critical STEVEN MCCULLOUGH
Publication of AU2001265248A1 publication Critical patent/AU2001265248A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0478—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group complexes from non-cyclic ligands, e.g. EDTA, MAG3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0489—Phosphates or phosphonates, e.g. bone-seeking phosphonates
AU2001265248A 2000-05-31 2001-05-31 Measurement of the therapeutic dose for bone marrow ablation therapy Abandoned AU2001265248A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US20815400P 2000-05-31 2000-05-31
US60/208,154 2000-05-31
PCT/US2001/017608 WO2001091806A2 (en) 2000-05-31 2001-05-31 Measurement of the therapeutic dose for bone marrow ablation therapy

Publications (1)

Publication Number Publication Date
AU2001265248A1 true AU2001265248A1 (en) 2001-12-11

Family

ID=22773401

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001265248A Abandoned AU2001265248A1 (en) 2000-05-31 2001-05-31 Measurement of the therapeutic dose for bone marrow ablation therapy

Country Status (2)

Country Link
AU (1) AU2001265248A1 (en)
WO (1) WO2001091806A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002062398A2 (en) * 2001-01-08 2002-08-15 Neorx Corporation Radioactively labelled conjugates of phosphonates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5871000A (en) * 1999-06-11 2001-01-02 Paul G. Abrams High dose radionuclide complexes for bone marrow suppression

Also Published As

Publication number Publication date
WO2001091806A2 (en) 2001-12-06
WO2001091806A9 (en) 2002-08-08
WO2001091806A3 (en) 2002-10-31

Similar Documents

Publication Publication Date Title
EP1059067B8 (en) Ablation treatment of bone metastases
EP1462134A4 (en) Administration instrument for medical use
AU2001258138A1 (en) Bone plate for the fixation of fractures of the proximal humerus
IL196301A0 (en) Medicament for the treatment of hapatitis c
HUP0200493A3 (en) Pharmaceutical compositions comprising sulphonyl-amino-carbonyl derivatives for the treatment of nuclear factor-kappa b mediated diseases
EP1408838A4 (en) An ultrasonic surgical instrument for intracorporeal sonodynamic therapy
IL169338A0 (en) Therapeutic formulations for the treatment of beta-amyloid related diseases
AU2001280440A1 (en) Treatment of human herpesviruses using hyperthermia
AU2002350235A1 (en) Combination bacteriolytic therapy for the treatment of tumors
IL141295A0 (en) Use of derivatives of aryl (or heteroaryl) azolycarbinols in the manufacture of a medicament for the treatment of disorders mediated by an excess of substance p
AU2003300791A1 (en) Combination therapy for the treatment of pain
AU7434101A (en) Treatment of bone diseases
EP1077704A4 (en) Combination therapy for treatment of depression
IL130572A0 (en) Terbenzimidazoles useful for medical therapy (topoisomerase inhibitors)
IL151890A0 (en) Hydroxyphenyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU3469400A (en) Pharmaceutical compositions for treatment of diseased tissues
AU2000274383A1 (en) Preparation for treating diseases of bone tissues
AU7731700A (en) Low dose ifn-gamma for treatment of disease
AU2317600A (en) Pressure-pulse therapy apparatus for treatment of tissue
HUP0104963A3 (en) Compositions for the treatment of skin diseases
IL151765A0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
IL151891A0 (en) Quinolinyl-piperidin 4-ylidene-methyl-benzamide derivatives for the treatment of pain
HUP0201405A3 (en) Pharmaceutical composition for therapeutic use of melatonin
IL142581A0 (en) Method of providing cosmetic/medical therapy
AU3851801A (en) Medical devices suitable for gene therapy regimens